Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | F10 | P00742 | 14/20 | 0.59 |
| ▸ | NPC1 | O15118 | 2/20 | 0.56 |
| ▸ | RAB9A | P51151 | 2/20 | 0.56 |
| ▸ | FGFR1 | P11362 | 2/20 | 0.53 |
| ▸ | KDR | P35968 | 2/20 | 0.53 |
| ▸ | AURKA | O14965 | 1/20 | 0.52 |
| ▸ | TTK | P33981 | 1/20 | 0.52 |
| ▸ | AURKB | Q96GD4 | 1/20 | 0.52 |
| ▸ | INCENP | Q9NQS7 | 1/20 | 0.52 |
| ▸ | KLKB1 | P03952 | 1/20 | 0.50 |
| ▸ | POLB | P06746 | 1/20 | 0.48 |
| ▸ | FGFR2 | P21802 | 1/20 | 0.48 |
| ▸ | FGFR3 | P22607 | 1/20 | 0.48 |
| ▸ | HDAC3 | O15379 | 1/20 | 0.48 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL30863551 | 0.91 | F10 (0.58) | F10NPC1RAB9AFGFR1KDR | |
| SCHEMBL30863513 | 0.86 | AURKA (0.53) | F10NPC1RAB9AFGFR1KDR | |
| SCHEMBL30863451 | 0.85 | HDAC3 (0.50) | F10FGFR1FGFR3HDAC3HDAC8 | |
| SCHEMBL27195758 | 0.83 | AURKA (0.53) | F10NPC1RAB9AAURKATTK | |
| Hydrochloric Acid SCHEMBL30863442 | 0.79 | NPC1 (0.54) | F10NPC1RAB9AAURKATTK | |
| SCHEMBL30863527 | 0.77 | HDAC3 (0.50) | F10FGFR1FGFR3HDAC3HDAC8 | |
| SCHEMBL27195706 | 0.76 | TRPV1 (0.58) | F10NPC1RAB9AAURKATTK | |
| SCHEMBL30863502 | 0.76 | HDAC3 (0.59) | F10NPC1RAB9AAURKATTK | |
| SCHEMBL27195914 | 0.76 | HDAC3 (0.59) | F10NPC1RAB9AAURKATTK | |
| Hydrochloric Acid SCHEMBL27195736 | 0.75 | AURKA (0.52) | F10NPC1RAB9AAURKATTK |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4581017-A1 | NEW N-HETEROARYLBENZAMIDES DERIVATIVES AS FLT3 INHIBITORS | Biodol Therapeutics (FR) | 2025-07-09 | — | — | EP | claimed |
| WO-2024079072-A1 | NEW N-HETEROARYLBENZAMIDES DERIVATIVES AS FLT3 INHIBITORS | BIODOL THERAPEUTICS (FR) | 2024-04-18 | — | — | WO | claimed |
| EP-4581017-A1 | NEW N-HETEROARYLBENZAMIDES DERIVATIVES AS FLT3 INHIBITORS | Biodol Therapeutics (FR) | 2025-07-09 | — | — | EP | disclosed |
| WO-2024079072-A1 | NEW N-HETEROARYLBENZAMIDES DERIVATIVES AS FLT3 INHIBITORS | BIODOL THERAPEUTICS (FR) | 2024-04-18 | — | — | WO | disclosed |